Zobrazeno 1 - 10
of 376
pro vyhledávání: '"Anna, Alisi"'
Autor:
Marica Meroni, Paola Dongiovanni, Francesca Tiano, Roberto Piciotti, Anna Alisi, Nadia Panera
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 180, Iss , Pp 117608- (2024)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) represents the most frequent cause of hepatic disorder, and its progressive form defined as Metabolic Dysfunction-Associated Steatohepatitis (MASH) contributes to the development of fib
Externí odkaz:
https://doaj.org/article/5e0be5481bd845a2bff36565149db130
Autor:
Maria Rita Braghini, Cristiano De Stefanis, Francesca Tiano, Aurora Castellano, Nicolo’ Cicolani, Marco Pezzullo, Valeria Tocco, Marco Spada, Rita Alaggio, Anna Alisi, Paola Francalanci
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundHepatoblastoma (HB) is the most common pediatric hepatic malignancy. Despite the progress in HB treatment, investigating HB pathomechanisms to optimize stratification and therapies remains a focal point to improve the outcome for high-risk
Externí odkaz:
https://doaj.org/article/8bd7b6029ac04845acc9a9b1c3c3f685
Autor:
Mariarosaria Ingegneri, Maria Rita Braghini, Michela Piccione, Cristiano De Stefanis, Manuela Mandrone, Ilaria Chiocchio, Ferruccio Poli, Martina Imbesi, Anna Alisi, Antonella Smeriglio, Domenico Trombetta
Publikováno v:
Antioxidants, Vol 13, Iss 7, p 869 (2024)
This study aims to recover the main by-product of Citrus fruits processing, the raw pomace, known also as pastazzo, to produce plant complexes to be used in the treatment of inflammatory bowel disease (IBD). Food-grade extracts from orange (OE) and l
Externí odkaz:
https://doaj.org/article/6d3bf3deec944a33aa92cd98f4b9e755
Autor:
Diana Buzova, Maria Rita Braghini, Salvatore Daniele Bianco, Oriana Lo Re, Marco Raffaele, Jan Frohlich, Antoniya Kisheva, Annalisa Crudele, Antonella Mosca, Maria Rita Sartorelli, Clara Balsano, Jan Cerveny, Tommaso Mazza, Anna Alisi, Manlio Vinciguerra
Publikováno v:
Hepatology Communications, Vol 6, Iss 12, Pp 3311-3323 (2022)
Abstract Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease in children and adolescents, increasing the risk of its progression toward nonalcoholic steatohepatitis (NASH), cirrhosis, and cancer. There is an urge
Externí odkaz:
https://doaj.org/article/1b6b8d15090c4306af647550858edf8e
Autor:
Flavia Grignaffini, Francesco Barbuto, Maurizio Troiano, Lorenzo Piazzo, Patrizio Simeoni, Fabio Mangini, Cristiano De Stefanis, Andrea Onetti Muda, Fabrizio Frezza, Anna Alisi
Publikováno v:
Diagnostics, Vol 14, Iss 4, p 388 (2024)
Digital pathology (DP) has begun to play a key role in the evaluation of liver specimens. Recent studies have shown that a workflow that combines DP and artificial intelligence (AI) applied to histopathology has potential value in supporting the diag
Externí odkaz:
https://doaj.org/article/1cb259c0c08f4a8cbe8e6990759cd5fb
Autor:
Antonella Mosca, Melania Manco, Maria Rita Braghini, Stefano Cianfarani, Giuseppe Maggiore, Anna Alisi, Andrea Vania
Publikováno v:
Metabolites, Vol 14, Iss 1, p 71 (2024)
Ecological theories suggest that environmental factors significantly influence obesity risk and related syndemic morbidities, including metabolically abnormal obesity associated with nonalcoholic fatty liver disease (MASLD). These factors encompass a
Externí odkaz:
https://doaj.org/article/547b8400b8a947dd83aba8d362d64255
Autor:
Christian A. Hudert, Leon A. Adams, Anna Alisi, Quentin M. Anstee, Annalisa Crudele, Laura G. Draijer, EU‐PNAFLD investigators, Samuel Furse, Jan G. Hengstler, Benjamin Jenkins, Kylie Karnebeek, Deirdre A. Kelly, Bart G. Koot, Albert Koulman, David Meierhofer, Phillip E. Melton, Trevor A. Mori, Stuart G. Snowden, Indra vanMourik, Anita Vreugdenhil, Susanna Wiegand, Jake P. Mann
Publikováno v:
Hepatology Communications, Vol 6, Iss 8, Pp 1934-1948 (2022)
Abstract Genome‐wide association studies in adults have identified variants in hydroxysteroid 17‐beta dehydrogenase 13 (HSD17B13) and mitochondrial amidoxime reducing component 1 (MTARC1) as protective against nonalcoholic fatty liver disease (NA
Externí odkaz:
https://doaj.org/article/3bb2c6a027504d0481422e3c44348ecb
Autor:
Maria Rita Braghini, Oriana Lo Re, Ilaria Romito, Maite G. Fernandez-Barrena, Barbara Barbaro, Silvia Pomella, Rossella Rota, Manlio Vinciguerra, Matias A. Avila, Anna Alisi
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-21 (2022)
Abstract Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer, being the sixth most commonly diagnosed cancer and the fourth leading cause of cancer-related death. As other heterogeneous solid tumours, HCC results from a unique sy
Externí odkaz:
https://doaj.org/article/751e8906da5d41f0852a7aad588e4016
Publikováno v:
Nutrition & Metabolism, Vol 19, Iss 1, Pp 1-16 (2022)
Abstract Background Nonalcoholic fatty liver disease (NAFLD) or more appropriately, metabolic associated fatty liver disease (MAFLD), is the hepatic manifestation of metabolic syndrome. An imbalance of copper homeostasis has been described in the pro
Externí odkaz:
https://doaj.org/article/1e78ce17a90e457dbb7aab493588748a
Autor:
Ilaria Romito, Manuela Porru, Maria Rita Braghini, Luca Pompili, Nadia Panera, Annalisa Crudele, Daniela Gnani, Cristiano De Stefanis, Marco Scarsella, Silvia Pomella, Stefano Levi Mortera, Emmanuel de Billy, Adrian Libenzio Conti, Valeria Marzano, Lorenza Putignani, Manlio Vinciguerra, Clara Balsano, Anna Pastore, Rossella Rota, Marco Tartaglia, Carlo Leonetti, Anna Alisi
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-6 (2022)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/7ea489c1d2f64a7ea2dea114313c315d